Drug intelligence / Profile preview

V3-750

Development stage
Preclinical
Lead developer
University of Oklahoma
Modality
Peptides
Administration
Intravenous
01

Overview

V3-750 is a pH-sensitive peptide-based imaging probe designed for the detection and intraoperative visualization of pancreatic ductal adenocarcinoma (PDAC). It consists of a pH low insertion peptide (pHLIP), specifically the V3 variant, conjugated to the near-infrared fluorescent dye HiLyte 750. The probe targets the acidic microenvironment characteristic of solid tumors; at low pH (typically 6.2–6.8 in pancreatic tumors), the peptide undergoes a conformational change that allows it to insert into the cell membrane, thereby localizing the fluorescent signal to the tumor site. This mechanism enables high-contrast imaging using multispectral optoacoustic tomography (MSOT) and near-infrared fluorescence (NIRF) imaging. Developed by researchers at the University of Oklahoma and the Military University Hospital Prague, V3-750 is intended to improve the identification of tumor margins and molecular features during surgery.

Other names
V3-HiLyte 750V-3-HiLyte 750V 3-HiLyte 750

Beyond the preview

Go deeper on V3-750.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V3-750.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call